投资界12月9日消息,苏州锐讯生物科技有限公司(简称“锐讯生物”)于近期正式完成C2轮数千万元人民币战略融资。本次由瑞江康圣领投。所募集资金将用于数字PCR产品国内外临床注册,欧洲市场推展和新产品研发,为锐讯生物持续在数字PCR领域和mRNA LNP领域保持领先地位提供强劲保障。通过本次融资,锐讯生物也将于 康圣环球 集团形成战略合作,未来在产品共同研发,国内临床产品入院,海外产品销售等领域深入...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.